A Study of Itacitinib in Combination With Low-Dose Ruxolitinib or Itacitinib Alone Following Ruxolitinib in Participants With Myelofibrosis
Clinical trial NCT03144687 · COMPLETED
Trial details
- NCT number
- NCT03144687
- Sponsor
- Incyte Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-26
- Primary completion
- 2020-03-14
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.